C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/078 (2010.01) C12N 5/071 (2010.01) A61K 35/14 (2006.01) A61K 35/28 (2006.01) C07K 16/28 (2006.01) G01N 33/566 (2006.01) G01N 33/569 (2006.01)
Patent
CA 2279474
The present invention relates to an antibody composition which contains antibodies specific for glycophorin A, CD2, CD3, CD14, CD15, CD16, CD19, CD24, CD56, CD66b and IgE antigens. A negative selection process is also provided for use on blood and bone marrow samples from a patient with chronic myeloid leukemia to recover cell preparations depleted of lineage committed cells. The invention also relates to kits for carrying out this process and to the cell preparations prepared by the process.
La présente invention concerne une préparation d'anticorps contenant des anticorps spécifiques pour la glycophorine A ainsi que les antigènes CD2, CD3, CD14, CD15, CD16, CD19, CD24, CD56, CD66b et IgE. L'invention porte aussi sur une méthode de sélection négative à utiliser avec des échantillons de sang et de moelle osseuse provenant d'un patient atteint de leucémie myéloïde chronique, méthode permettant d'obtenir des préparations cellulaires exemptes de cellules engagées dans une voie de différenciation. L'invention touche également les trousses permettant la mise en ouvre de cette méthode et les préparations cellulaires obtenues par cette méthode.
Eaves Connie J.
Thomas Terry E.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Stemcell Technologies Inc.
LandOfFree
Novel antibody composition for debulking blood and bone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel antibody composition for debulking blood and bone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel antibody composition for debulking blood and bone... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1935828